Blood Pressure Medication Recalled Over Cancer-Causing Chemical

The U.S. Food and Drug Administration in White Oak, Md., on July 20, 2020. Sarah Silbiger/Getty Images

Aurobindo Pharma USA is voluntarily recalling two lots of blood pressure medication because of high levels of nitrosamine, the U.S. Food and Drug Administration (FDA) said.

The New Jersey-based company initiated the recall of quinapril and hydrochlorothiazide in 20 milligram and 12.5 milligram tablets due to the presence of the chemical, which is associated with a higher risk of cancer. The tablets are used to treat high blood pressure.